Looking Forward
The science of rare diseases is advancing with each new day. NIH is promoting innovation to translate promising early work into clinical trials. Orphan product development is being seen by many as the most exciting frontier in the pharmaceutical and biotechnology industries today. In this section of the website, we will post news throughout the year about major developments on Capitol Hill, in the research lab, and on the regulatory front to drive progress toward safe, effective treatments for all people affected by rare diseases.
